The success of GLP-1 receptor agonists/analogues has transformed metabolic disease treatment while demonstrating the potential of engineered peptides to deliver long-acting, highly targeted therapies.

Reach customers where they live, work, and scroll. With 665,386 unique visits in the past 28 days alone, timesleader.com stands as one of the most highly trafficked websites in Northeastern ...

May 6, 2026 Cumberland, B.C. is reimagining its coal mining past as a clean energy opportunity. Water trapped in abandoned mine tunnels could be used in a geothermal system to heat and cool buildings ...

Ranked by Value of all metro-area SBA loans in 2025 Ranked by Total local employees Ranked by Total Closings Wilmington Trust is pleased to welcome Kristen Stevenson as a Senior Wealth Advisor in its… ...